Alzheimer's Disease

Citations 1-10 of 123 total displayed.

Most recent content (1 Sep 2009):

Letters to the Editor
Nonsignificant Weight Gain With Atypical Antipsychotics in Men With Alzheimer’s Disease: An Important Result of the CATIE-Alzheimer’s Disease Study

BHAVANI SHANKARA BAGEPALLY and OM PRAKASH
Am J Psychiatry 2009; 166: 1063-b-1064-b. [Full text] [PDF]  

Letters to the Editor
Drs. Schneider, Zheng, and Mack Reply

LON S. SCHNEIDER, LING ZHENG, and WENDY J. MACK
Am J Psychiatry 2009; 166: 1064-1065. [Full text] [PDF]  

Past content (since Jan 1996):

Articles
Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study

Ling Zheng, Wendy J. Mack, Karen S. Dagerman, John K. Hsiao, Barry D. Lebowitz, Constantine G. Lyketsos, T. Scott Stroup, David L. Sultzer, Pierre N. Tariot, Cheryl Vigen, and Lon S. Schneider
Am J Psychiatry 2009; 166: 583-590. [Abstract] [Full text] [PDF]  

Articles
Older Adults’ Attitudes Toward Enrollment of Non-competent Subjects Participating in Alzheimer’s Research

Jason Karlawish, Jonathan Rubright, David Casarett, Mark Cary, Thomas Ten Have, and Pamela Sankar
Am J Psychiatry 2009; 166: 182-188. [Abstract] [Full text] [PDF]  

Editorials
The Effects of Stress and APOE Genotype on Cognition in Older Adults

Guerry M. Peavy
Am J Psychiatry 2008; 165: 1376-1378. [Full text] [PDF]  

Articles
Apolipoprotein E Genotype, Cortisol, and Cognitive Function in Community-Dwelling Older Adults

Brian K. Lee, Thomas A. Glass, Gary S. Wand, Matthew J. McAtee, Karen Bandeen-Roche, Karen I. Bolla, and Brian S. Schwartz
Am J Psychiatry 2008; 165: 1456-1464. [Abstract] [Full text] [PDF]  

Letters to the Editor
The Use of Iconic Symbols to Represent Our Experience

HOWARD L. BERKOWITZ
Am J Psychiatry 2008; 165: 1051. [Full text] [PDF]  

Editorials
Atypical Antipsychotic Medications in Alzheimer’s Disease: Effectiveness Versus Expectations

Susan K. Schultz
Am J Psychiatry 2008; 165: 787-789. [Full text] [PDF]  

Articles
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial

David L. Sultzer, Sonia M. Davis, Pierre N. Tariot, Karen S. Dagerman, Barry D. Lebowitz, Constantine G. Lyketsos, Robert A. Rosenheck, John K. Hsiao, Jeffrey A. Lieberman, Lon S. Schneider, and CATIE-AD Study Group
Am J Psychiatry 2008; 165: 844-854. [Abstract] [Full text] [PDF]  

Articles
A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH₁ Antagonist) in the Treatment of Major Depression

Brendon Binneman, Douglas Feltner, Sheela Kolluri, Yuanjun Shi, Ruolun Qiu, and Thomas Stiger
Am J Psychiatry 2008; 165: 617-620. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13